Company & Sponsor Intelligence
Boston University Charles River Campus
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting0
Completed6
Countries1
Therapeutic footprint
autismdepressionother_psychiatryparkinsons
Indexed studies
NCT03625999A Novel Intervention for Training Auditory Attention in Adolescents With Autism Spectrum Disorder
autism · United StatesNA
autism · United StatesNA
NCT03374072Engaging Siblings of Adults With Autism in Future Planning
autism · United StatesNA
autism · United StatesNA
NCT00586001A Unified Treatment for Anxiety Disorders
depression · NA
depression · NA
NCT02700074Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder
autism · United StatesCOMPLETED
autism · United StatesCOMPLETED
NCT02784938Vocational Empowerment Photovoice (VEP)
other_psychiatry · United StatesNA
other_psychiatry · United StatesNA
NCT03517371Walking and mHealth to Increase Participation in Parkinson Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT05965648Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →